Ata uhi

Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

I tiakina i:
I whakaputaina i:The New England Journal of Medicine vol. 384, no. 17 (Apr 29, 2021), p. 1589
Kaituhi matua: Pergola, Pablo E
Ētahi atu kaituhi: Farag Youssef MK, Agarwal Rajiv, Arnold, Susan, Bako Gabriel, Block, Geoffrey A, Burke, Steven, Castillo, Fausto P, Jardine, Alan G, Khawaja Zeeshan, Koury, Mark J, Lewis, Eldrin F, Lin, Tim, Luo Wenli, Maroni, Bradley J, Matsushita Kunihiro, McCullough, Peter A, Parfrey, Patrick S, Roy-Chaudhury, Prabir, Sarnak, Mark J, Sharma, Amit, Spinowitz Bruce, Tseng, Carol, Tumlin, James, Vargo, Dennis L, Walters, Kimberly A, Winkelmayer, Wolfgang C, Wittes Janet, Eckardt Kai-Uwe
I whakaputaina:
Massachusetts Medical Society
Ngā marau:
Akebia Therapeutics Inc
United States > US
Hemodialysis
Clinical trials
Hypoxia-inducible factors
Hemoglobin
Cerebral infarction
Collaboration
Kidney diseases
Heart failure
Hypoxia
Myocardial infarction
Confidence intervals
Erythropoietin
Thromboembolism
Drug dosages
Erythropoiesis
Patients
Hydroxylase
Anemia
Heart attacks
Prolyl hydroxylase
Design
Safety
Congestive heart failure
Dialysis
Urunga tuihono:Citation/Abstract
Full Text
Full Text - PDF
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
Me noho koe te mea tuatahi ki te waiho tākupu!
Me takiuru i te tuatahi